Evidence map›Paper›PMID 38904396›Full record

ArticlemSphere2024

Synthetic lethality and the minimal genome size problem.

Sara Rahiminejad, Bianca De Sanctis, Pavel Pevzner, Arcady Mushegian

Abstract read
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sara RahiminejadDepartment of Bioengineering, University of California-San Diego, La Jolla, California, USA.
Bianca De SanctisDepartment of Genetics, University of Cambridge, Cambridge, United Kingdom.
Pavel PevznerDepartment of Computer Science and Engineering, University of California-San Diego, La Jolla, California, USA.
Arcady MushegianMolecular and Cellular Biosciences Division, National Science Foundation, Alexandria, Virginia, USA.ORCID 0000-0002-6809-9225

Funding

National Science Foundation (NSF) Long-Term Professional Development programWellcome TrustWellcome Trust (WT) WT220023
6 · The paper itself

Abstract

Gene knockout studies suggest that ~300 genes in a bacterial genome and ~1,100 genes in a yeast genome cannot be deleted without loss of viability. These single-gene knockout experiments do not account for negative genetic interactions, when two or more genes can each be deleted without effect, but their joint deletion is lethal. Thus, large-scale single-gene deletion studies underestimate the size of a minimal gene set compatible with cell survival. In yeast

Indexed as

Genome, FungalGenome SizeSaccharomyces cerevisiaeAlgorithmsGene DeletionGene Knockout TechniquesModels, GeneticSynthetic Lethal Mutationsbacteriaminimal gene setminimal genome sizesynthetic lethalityyeast

Identifiers

PMID38904396
PMCPMC11288024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.